AzTrials
AzTrials

Sore ThroatNCT05317520

The Effect of Cold Vapor Application on Postoperative Sore Throat

A study testing Cold vapor in people with Sore Throat, run by Burdur Mehmet Akif Ersoy University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

To determine the effect of cold vapor given in the post-extubation period on sore throat. Read more about this study

Who is it for?
Ages 18 to 80 years
Conditions the study is for
Sore Throat
What is being tested?
Cold vapor
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
64 participants
Where
1 siteTurkey (Türkiye)
Study dates
16 Dec 2016to 17 May 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Those who accept the research
  • Elective laparoscopic cholecystectomy surgery planned
  • Patients in ASA I and II class
  • 18 years and over
  • Mallampati classification I and II
  • Operation time more than 30 minutes
Show all 9Show fewer
  • Literate
  • No hearing problem
  • Patients without understanding difficulties

Who cannot join

  • Overweight patients (Body Mass Index ≥ 40)
  • Patients with sore throat and lower respiratory tract infection
  • Patients with Chronic Obstructive Pulmonary Disease (COPD)
  • Patients with a history of allergies
  • Patients with hearing problems
  • illiterate patients
Show all 9Show fewer
  • ASA classification III and above
  • Mallampati classification III and IV patients
  • Patients with an operation time of less than 30 minutes

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Hatice Özsoy

    Merkez, Burdur

Other trials in Turkey (Türkiye)

About this study

Official title: The Effect of Cold Vapor Application on Sore Throat in The Patients Extubated After Surgery: A Randomized Control Trial

To determine the effect of cold vapor given in the post-extubation period on sore throat.

Read the detailed description

General anesthesia increases the comfort of the patient by ensuring that the patient does not feel the surgical interventions and pain during the operation. The necessity of intubation is known in patients who have undergone surgery under general anesthesia. Intubation provides benefits such as keeping the airway open, controlling the airway and breathing, reducing respiratory effort and dead space volume, preventing aspiration, and facilitating resuscitation in case of any problem.

Although surgical interventions are an important treatment option for health problems, postoperative complications such as sore throat, dry throat, hoarseness and dysphagia due to laryngeal and pharyngeal traumas caused by intubation are frequently observed especially in patients receiving general anesthesia.

Although it is seen in the literature that pharmacological, non-pharmacological and herbal methods are applied to reduce postoperative sore throat, there are not enough studies examining the effect of cold steam application on sore throat. With this research, it is expected that the cold steam given in the postoperative period will contribute to the relief of sore throat.

Conditions
Sore Throat
Being tested
Cold vapor
Keywords
Extubation, Sore throat, Cold vapor, Nursing
Medical subject headings
Pharyngitis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Cold vaporProcedure or surgery

    The Ramsey Sedation Scale was used to assess wakefulness after patients were extubated and arrived at the recovery unit at the 0th hour postoperatively. Sore throat, localization of pain, hoarseness, dry throat, and swallowing difficulty were evaluated in patients with a score of 2 according to this scale. Sore throat of the patients was evaluated with Numerical Rating Scale. Then, cold vapor was applied for 15 minutes with a vapor machine used as a standard in the hospital by the researcher. After the cold vapor application was finished, the patients' sore throat, localization of pain, hoarseness, swallowing difficulty and dry throat were re-evaluated with the same forms.

    Sore throat were evaluated before the application of cold vapor at the 2nd and 6th hours. Then cold vapor was applied for 15 minutes. After the cold vapor application was finished, sore throat were re-evaluated.

    At the 24th hour, cold vapor was not applied to the patients. Only sore throat were evaluated.

Study groups in NCT05317520
Study groupRoleWhat they receive
Intervention groupExperimentalCold vapor was applied 3 times in total at 0th,2nd and 6th hours.
Receives: Procedure: Cold vapor
Control groupNo interventionNo cold vapor was applied at 0th,2nd and 6th hours.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Sore throat

    In our study, a horizontally prepared Numerical Rating Scale was used to evaluate the severity of pain. Patients participating in the study were asked to rate the severity of their sore throat on a scale of 0 to 10. The scale begins with the absence of pain (0) and ends with excruciating pain (10).

    When the patient came to the recovery unit, the severity of sore throat was evaluated before and after the application of cold vapor at 0th hour.

    Measured: Within an hour after surgery

  2. Sore throat

    In our study, a horizontally prepared Numeric Rating Scale was used to evaluate the severity of pain. Patients participating in the study were asked to rate the severity of sore throat between 0 and 10. The scale starts with the absence of pain (0) and ends with unbearable pain (10).

    The severity of sore throat was evaluated before and after the application of cold vapor at 2nd hour postoperatively.

    Measured: 2nd hour after surgery

  3. Sore throat

    In our study, a horizontally prepared Numeric Rating Scale was used to evaluate the severity of pain. Patients participating in the study were asked to rate the severity of sore throat between 0 and 10. The scale starts with the absence of pain (0) and ends with unbearable pain (10).

    The severity of sore throat was evaluated before and after the application of cold vapor at 6th hour postoperatively.

    Measured: 6th hour after surgery

  4. Sore throat

    In our study, a horizontally prepared Numeric Rating Scale was used to evaluate the severity of pain. Patients participating in the study were asked to rate the severity of sore throat between 0 and 10. The scale starts with the absence of pain (0) and ends with unbearable pain (10).

    Cold vapor was not applied to the patients at the 24th hour.. Only sore throat were evaluated.

    Measured: 24th hour after surgery

Secondary outcomes (8)
  1. Hoarseness

    To assess hoarseness, patients were asked a single question, "Do you have any hoarseness in your voice now?" Participants were asked to evaluate this question with a 4-point Likert-type rating.Rating; 0 = no hoarseness, 1 = slow, hoarse voice, 2 = moderate hoarseness (clear during the interview), 3 = hoarseness (completely silent, no speech).

    When the patient came to the recovery unit, the severity of hoarseness was evaluated before and after the application of cold vapor at the 0th hour.

    Measured: Within an hour after surgery

  2. Hoarseness

    To assess hoarseness, patients were asked a single question, "Do you have any hoarseness in your voice now?" Participants were asked to evaluate this question with a 4-point Likert-type rating. Rating; 0 = no hoarseness, 1 = slow, hoarse voice, 2 = moderate hoarseness (clear during the interview), 3 = hoarseness (completely silent, no speech).

    The severity of hoarseness was evaluated before and after the application of cold vapor at the 2nd hour postoperatively.

    Measured: 2nd hour after surgery

  3. Hoarseness

    To assess hoarseness, patients were asked a single question, "Do you have any hoarseness in your voice now?" Participants were asked to evaluate this question with a 4-point Likert-type rating. Rating; 0 = no hoarseness, 1 = slow, hoarse voice, 2 = moderate hoarseness (clear during the interview), 3 = hoarseness (completely silent, no speech).

    The severity of hoarseness was evaluated before and after the application of cold vapor at the 6th hour postoperatively.

    Measured: 6th hour after surgery

  4. Hoarseness

    To assess hoarseness, patients were asked a single question, "Do you have any hoarseness in your voice now?" Participants were asked to evaluate this question with a 4-point Likert-type rating. Rating; 0 = no hoarseness, 1 = slow, hoarse voice, 2 = moderate hoarseness (clear during the interview), 3 = hoarseness (completely silent, no speech).

    Cold vapor was not applied to the patients at the 24th hour. Only hoarseness was evaluated.

    Measured: 24th hour after surgery

  5. Dry throat and swallowing difficulty

    The patients were asked to rate the severity of dry throat and swallowing difficulty between 0 and 4 (0=None, 1=Mild, 2=Moderate, 3=Extreme, 4=Unbearable).

    When the patient came to the recovery unit, the severity of throat dryness and swallowing difficulty was evaluated before and after the application of cold vapor at the 0th hour.

    Measured: Within an hour after surgery

  6. Dry throat and swallowing difficulty

    The patients were asked to rate the severity of dry throat and swallowing difficulty between 0 and 4 (0=None, 1=Mild, 2=Moderate, 3=Extreme, 4=Unbearable).

    At the 2nd hour postoperatively, the severity of throat dryness and swallowing difficulty were evaluated before and after the application of cold vapor.

    Measured: 2nd hour after surgery

  7. Dry throat and swallowing difficulty

    The patients were asked to rate the severity of dry throat and swallowing difficulty between 0 and 4 (0=None, 1=Mild, 2=Moderate, 3=Extreme, 4=Unbearable).

    At the 6th hour postoperatively, the severity of throat dryness and swallowing difficulty were evaluated before and after the application of cold vapor.

    Measured: 6th hour after surgery

  8. Dry throat and swallowing difficulty

    The patients were asked to rate the severity of dry throat and swallowing difficulty between 0 and 4 (0=None, 1=Mild, 2=Moderate, 3=Extreme, 4=Unbearable).

    Cold vapor was not applied to the patients at the 24th hour. Only dry throat and swallowing difficulty were evaluated.

    Measured: 24th hour after surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Apr 2022
  2. Study start16 Dec 2016
  3. Primary completion17 Aug 2017
  4. Study completion17 May 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
Patients were divided into intervention and control groups using a simple randomized control method.
Masking
None (open label)
Enrolment
64 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05317520
Sponsor's protocol ID
Mehmet Akif Ersoy University
Status last verified
Apr 2022
First submitted
27 Jul 2021
Last updated
14 Apr 2022
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: The data sets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

Questions about this trial

What is this clinical trial studying?

A study testing Cold vapor in people with Sore Throat, run by Burdur Mehmet Akif Ersoy University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 14 Apr 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Sore throat (time frame: Within an hour after surgery). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Apr 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in